NCT02500862

Brief Summary

Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Sep 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Sep 2015Dec 2026

First Submitted

Initial submission to the registry

July 10, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 17, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
11.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

11.3 years

First QC Date

July 10, 2015

Last Update Submit

July 29, 2024

Conditions

Eye Disease

Keywords

EyeImaging

Outcome Measures

Primary Outcomes (1)

  • Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI.

    10 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Any patient followed under the normal clinical practice at AIBILI Clinical Trial Centre, and with a AIBILI signed informed consent form for data collection, Imp. 11-7-2 "Consentimento Informado para tratamento de dados".

You may qualify if:

  • Any patient followed under the normal clinical practice at AIBILI Clinical Trial Centre, and with a AIBILI signed informed consent form for data collection, Imp. 11-7-2 "Consentimento Informado para tratamento de dados".

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CEC

Coimbra, 3000-548, Portugal

Location

MeSH Terms

Conditions

Eye Diseases

Study Officials

  • Maria L Ribeiro, MsC

    Association for Innovation and Biomedical Research on Light and Image

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2015

First Posted

July 17, 2015

Study Start

September 1, 2015

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 30, 2024

Record last verified: 2024-07

Locations

PT(1)